856253-93-5Relevant academic research and scientific papers
Study of small oligomers based on Ru2(DMBA)4 and meta-phenylene diethynylene
Ying, Jie-Wen,Liskey, Carl W.,Natoli, Sean N.,Betancourt, Stella K.,Liu, Li,Fanwick, Phillip E.,Ren, Tong
, p. 293 - 298 (2017/09/30)
The reactions between Ru2 (DMBA)4(NO3)2 (DMBA = N,N’-dimethylbenzamidinate) and meta-phenylene diethynylenes bearing 5-ester substituents (-CO2iPr, L1; -CO2Bn, L2) in the presenc
METHODS FOR TREATING RETINOID RESPONSIVE DISORDERS USING SELECTIVE INHIBITORS OF CYP26A AND CYP26B
-
Page/Page column 248, (2008/06/13)
The invention provides methods for treating an individual having a retinoid responsive disorder. In one embodiment, a method involves administering to the individual an effective amount of a selective CYP26B inhibitor, the selective CYP26B inhibitor having at least 10-fold selectivity for CYP26B relative to CYP26A. In another embodiment, a method involves administering to the individual an effective amount of a selective CYP26A inhibitor, the selective CYP26A inhibitor having a chemical formula set forth in the specification. The invention further provides screening methods for identifying a selective CYP26A inhibitor or selective CYP26B inhibitor.
COMPOUNDS HAVING SELECTIVE CYTOCHROME P450RAI-1 OR SELECTIVE CYTOCHROME P450RAI-2 INHIBITORY ACTIVITY AND METHODS OF OBTAINING THE SAME
-
Page/Page column 204, (2010/02/12)
Compounds of formulas 1 through 17 provided in the specification specifically or selectively inhibit either the cytochrome P450RAI-1 enzyme or the cytochrome P450RAI-2 enzyme.
